PATENT CLAIM ANALYSIS

Application Number: 16297599
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "161000"]

Abstract:
Disclosed herein are methods of preventing, inhibiting, reducing, or treating ischemia and reperfusion injury to tissues with glutarate compounds such as α-ketoglutarate.

Claim (Index 25):
The method of  claim 21 , wherein R 2  is \u2014OR 7  or \u2014NR 8 R 9 .

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15582748', '15522969', '16027029', '15123232', '15083836']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8042739575157775
- 35 USC 102 Novelty (BERT): 0.5721946448755137
- Combined Prediction Score: 0.781066026251751
- Mean Citation Score: 347.373964
- Max Citation Score: 555.04926
- Similarity Product: 336.4079253464913

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test